ANSTO awarded an Athena Bronze Institution Award
ANSTO has been awarded an Athena Bronze Institution Award, acknowledging our dedication to improving workplace equality, diversity and inclusion.
Showing 1381 - 1400 of 2859 results
ANSTO has been awarded an Athena Bronze Institution Award, acknowledging our dedication to improving workplace equality, diversity and inclusion.
ANSTO continues a longstanding, mutually-beneficial research relationship with the University of Wollongong following the signing of a strategic agreement this week.
This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors and platform users and collaborators safe and minimise the risk of the spread of COVID-19 infection.
ANSTO providing support to emergency services, closed to non-essential staff.
ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week. Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.
The installation of a cold neutron source (CNS), a component that reduces the energy and speed of the neutrons from a research reactor for use in scientific instruments, was successfully completed in September 2024.
A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.
Research to improve knowledge of natural variability in rainfall and recharge by monitoring hydrological processes in key regions and reconstruct water recharge history.
The Biosciences team undertakes the radiolabelling of chemical, biochemical. biological or material vector for the purpose of radiotracing in living systems.
Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.
Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.
ANSTO is pleased to welcome The Hon Dr Annabelle Bennett AO SC as the new ANSTO Board Chairperson, following the announcement from the Minister for Industry, Science and Technology.
Minerals Principal Consultant, Dr Karin Soldenhoff, was honoured with the 2024 NSW Women in Mining -Technological Innovation award last week for her work as technical lead on the Australia Strategic Metals (ASM) Dubbo Project, and development of a new solvent extraction technology to separate rare earth and other critical elements.